arrow
R

Raffaele Cozzolongo

national institute of gastroenterology s de bellis
H指数:28
被引数:2,892

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites

术前血清白蛋白浓度预测肝硬化伴腹水患者长期输注白蛋白的临床获益

2026-07-300
OAAI
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian Paradigm

乙型肝炎病毒感染对原住民和移民的医疗影响:意大利范例

2025-07-290
OAAI
Burden of Hepatitis D Virus infection in Italy: final results from the HDV Describe study
2025-03-010
PRE
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study
2024-07-060
OAAI
Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet
2024-05-083
OAAI
Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity
2024-03-180
OAAI
Efficacy and safety of lusutrombopag in a real-world Italian series of cirrhotic patients with severe thrombocytopenia undergoing invasive procedures: the Reality study
2024-02-010
PRE
Prevalence and Characterization of Resistance Profiles of Unusual HCV Subtypes in Italy within the Italian Resistance Network Vironet C
2024-02-010
PRE
Long-term albumin administration improves survival in out-patients with decompensated cirrhosis and diabetes: post-hoc analysis of the ANSWER Trial
2024-02-010
PRE
Burden of Hepatitis D Virus infection in Italy: interim results from a prospective multicentre nationwide study
2024-02-011
PRE
Associations between serum biomarkers and non-alcoholic liver disease: results of a clinical study of Mediterranean patients with obesity (vol 9, 1002669, 2022)

血清生物标志物与非酒精性肝病之间的关联: 地中海肥胖患者的临床研究结果 (第9卷,1002669,2022)

2023-05-040
OAAI